Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report)’s share price shot up 11.8% during mid-day trading on Monday . The company traded as high as $11.23 and last traded at $11.22. 489,633 shares were traded during trading, a decline of 40% from the average session volume of 809,964 shares. The stock had previously closed at […]
Phathom Pharmaceuticals (NASDAQ:PHAT – Get Free Report) will release its earnings data before the market opens on Thursday, May 9th. Analysts expect Phathom Pharmaceuticals to post earnings of ($1.13) per share for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link. Phathom Pharmaceuticals (NASDAQ:PHAT – Get […]
Phathom Pharmaceuticals (NASDAQ:PHAT – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at Needham & Company LLC in a note issued to investors on Friday, Benzinga reports. They presently have a $26.00 price target on the stock. Needham & Company LLC’s price objective suggests a potential upside of 188.89% from the […]
Needham & Company LLC reissued their buy rating on shares of Phathom Pharmaceuticals (NASDAQ:PHAT – Free Report) in a report published on Monday morning, Benzinga reports. Needham & Company LLC currently has a $26.00 target price on the stock. Phathom Pharmaceuticals Price Performance Shares of NASDAQ:PHAT opened at $10.62 on Monday. Phathom Pharmaceuticals has a […]
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report)’s stock price gapped up prior to trading on Thursday after the company announced better than expected quarterly earnings. The stock had previously closed at $9.73, but opened at $10.49. Phathom Pharmaceuticals shares last traded at $9.42, with a volume of 136,494 shares. The company reported ($0.80) earnings […]